Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lisata Therapeutics (LSTA) Return on Sales (2016 - 2025)

Historic Return on Sales for Lisata Therapeutics (LSTA) over the last 12 years, with Q3 2025 value amounting to 17.05%.

  • Lisata Therapeutics' Return on Sales changed N/A to 17.05% in Q3 2025 from the same period last year, while for Sep 2025 it was 17.05%, marking a year-over-year change of. This contributed to the annual value of 19.98% for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Lisata Therapeutics' Return on Sales is 17.05%.
  • Lisata Therapeutics' Return on Sales' 5-year high stood at 4.61% during Q4 2024, with a 5-year trough of 66.56% in Q2 2025.